Stuart Thompson

464 total citations
8 papers, 362 citations indexed

About

Stuart Thompson is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Stuart Thompson has authored 8 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Stuart Thompson's work include Pancreatic and Hepatic Oncology Research (2 papers), Fibroblast Growth Factor Research (2 papers) and Ubiquitin and proteasome pathways (2 papers). Stuart Thompson is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Fibroblast Growth Factor Research (2 papers) and Ubiquitin and proteasome pathways (2 papers). Stuart Thompson collaborates with scholars based in United Kingdom. Stuart Thompson's co-authors include John Watkinson, A. J. N. Prichard, Kenneth K. Iwata, Elizabeth Buck, Neil W. Gibson, Pablo J. Cagnoni, John D. Haley, Alexandra Eyzaguirre, Sharon Barr and David B. Young and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.

In The Last Decade

Stuart Thompson

7 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stuart Thompson United Kingdom	6	159	150	109	76	62	8	362
Paul Waring Australia	7	171 1.1×	177 1.2×	95 0.9×	134 1.8×	42 0.7×	10	427
Eisei Shin Japan	10	175 1.1×	96 0.6×	42 0.4×	33 0.4×	66 1.1×	16	258
Albin Rudisch Austria	6	151 0.9×	178 1.2×	42 0.4×	20 0.3×	90 1.5×	7	325
Qinghai Ji China	9	65 0.4×	83 0.6×	50 0.5×	37 0.5×	35 0.6×	22	240
Ingrid Lua United States	11	76 0.5×	118 0.8×	45 0.4×	133 1.8×	42 0.7×	16	415
S. J. Lee United Kingdom	8	56 0.4×	212 1.4×	170 1.6×	46 0.6×	78 1.3×	10	465
J. H. Finke United States	6	175 1.1×	97 0.6×	65 0.6×	65 0.9×	145 2.3×	9	395
Juan Antonio Barrera Spain	5	161 1.0×	151 1.0×	106 1.0×	13 0.2×	132 2.1×	7	299
H Sakai Japan	6	105 0.7×	357 2.4×	51 0.5×	98 1.3×	78 1.3×	8	486
Liran Zhou United States	8	100 0.6×	213 1.4×	64 0.6×	24 0.3×	72 1.2×	10	324

Countries citing papers authored by Stuart Thompson

Since Specialization

Citations

This map shows the geographic impact of Stuart Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Thompson more than expected).

Fields of papers citing papers by Stuart Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Thompson. The network helps show where Stuart Thompson may publish in the future.

Co-authorship network of co-authors of Stuart Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Thompson. A scholar is included among the top collaborators of Stuart Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Thompson. Stuart Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Thompson, Stuart, et al.. (2025). Abstract 7004: CT7439 an oral first-in class selective CDK12 and 13 inhibitor and cyclin K degrader: Profiling activity and combination efficacy in an ovarian cancer model. Cancer Research. 85(8_Supplement_1). 7004–7004.

Crabb, Simon J., Alison Birtle, Karen Martin, et al.. (2017). ProCAID: a phase I clinical trial to combine the AKT inhibitor AZD5363 with docetaxel and prednisolone chemotherapy for metastatic castration resistant prostate cancer. Investigational New Drugs. 35(5). 599–607. 37 indexed citations

Crabb, Simon J., Alison Birtle, Karen Martin, et al.. (2016). ProCAID: A phase I clinical trial to combine the AKT inhibitor AZD5363 with docetaxel and prednisolone (DP) chemotherapy for metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 34(2_suppl). 228–228. 3 indexed citations

Buck, Elizabeth, Alexandra Eyzaguirre, Sharon Barr, et al.. (2007). Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition. Molecular Cancer Therapeutics. 6(2). 532–541. 158 indexed citations

Thompson, Stuart & A. J. N. Prichard. (2004). The management of parathyroid carcinoma. Current Opinion in Otolaryngology & Head & Neck Surgery. 12(2). 93–97. 39 indexed citations

Cocks, Helen, Stuart Thompson, Ann Logan, et al.. (2003). Role and regulation of the fibroblast growth factor axis in human thyroid follicular cells. American Journal of Physiology-Endocrinology and Metabolism. 285(3). E460–E469. 14 indexed citations

Thompson, Stuart, Jayne A. Franklyn, John Watkinson, et al.. (1998). Fibroblast Growth Factors 1 and 2 and Fibroblast Growth Factor Receptor 1 Are Elevated in Thyroid Hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 83(4). 1336–1341. 50 indexed citations

Thompson, Stuart, et al.. (1995). Papillary carcinoma arising in a thyroglossal duct cyst: a case report and literature review. The Journal of Laryngology & Otology. 109(11). 1124–1127. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact